Table 4.
DAT | ZJ0273 (mg/L) | ALS activity (OD530/(g FW·min)) | GST activity (nmol/(min·mg protein)) |
5 | 0 | 1.87±0.16a | 5.85±0.31c |
100 | 1.83±0.36a | 7.76±0.76b | |
500 | 1.62±0.41b | 11.30±0.81a | |
1000 | 1.34±0.35c | 11.83±1.48a | |
10 | 0 | 1.90±0.45a | 6.61±0.53b |
100 | 1.81±0.42a | 8.05±0.66b | |
500 | 1.59±0.24b | 12.84±1.07a | |
1000 | 1.21±0.52c | 14.04±2.14a | |
15 | 0 | 2.07±0.21a | 6.59±0.50d |
100 | 1.69±0.19b | 10.41±0.61c | |
500 | 1.52±0.38c | 13.86±1.12b | |
1000 | 1.03±0.41d | 16.05±0.86a | |
20 | 0 | 2.15±0.22a | 6.62±0.46d |
100 | 1.65±0.25b | 15.40±1.04c | |
500 | 1.47±0.19c | 17.93±0.94b | |
1000 | 0.91±0.17d | 20.90±1.61a |
Within a column, means at the same DAT followed by the same letters are not significantly different by the LSD test at P≤0.05 under completely randomized design. Data were analyzed separately at each measurement time. Values are expressed as mean±SE (n=3). DAT: days after treatment; ALS: acetolactate synthase; GST: glutathione transferase; OD530: optical density at 530 nm; FW: fresh weight